Skip to main content
Fig. 4 | Clinical Epigenetics

Fig. 4

From: Methylome and transcriptome analyses reveal insights into the epigenetic basis for the good survival of hypomethylated ER-positive breast cancer subtype

Fig. 4

CpG sites with methylation differences between the two ER-positive BRCA subgroups. a Percentage of hypermethylated and hypomethylated sites between hypo-ER-positive and hyper-ER-positive cancer subgroups. b Survival curve in the two subgroups based on the methylation level of the 2772 hypo-DMCs. c Distribution of hypo-DMCs in various genomic sequences. d Genes with hypo-DMCs enriched in pathways related with cancer

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us